ETOPOSIDE, ATEZOLIZUMAB, PF-08634404, CARBOPLATIN
C6461004
Phase 3 small_molecule active
Quick answer
ETOPOSIDE, ATEZOLIZUMAB, PF-08634404, CARBOPLATIN for Extensive-Stage Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Extensive-Stage Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active